StonvexLoading…
StonvexStonvexStonvexSide-by-side peer comparison: valuation, growth, margin, and Activity Index.
Theme: biotech · 9 peers
Best-in-column highlighted in green, worst in red. Sorted by Activity Index.
| Rank | Ticker | Price | Day | Mkt Cap | P/E | P/S | Rev YoY | Gross M. | Activity Index |
|---|---|---|---|---|---|---|---|---|---|
| You | HALO Halozyme Therapeutics | $69.21 | -1.17% | — | — | — | — | — | 42 |
| 1 | NVO Novo Nordisk | $45.80 | -2.68% | — | — | — | — | — | 67 |
| 2 |
Fundamentals via Finnhub (TTM). Quotes near real-time. Activity Index is Stonvex's proprietary momentum/sentiment composite, not investment advice.
| $50.03 |
| -0.97% |
| — |
| — |
| — |
| — |
| — |
| 54 |
| 3 | TEM Tempus AI | $45.48 | -0.51% | — | — | — | — | — | 52 |
| 4 | REGN Regeneron | $712.87 | -0.97% | — | — | — | — | — | 52 |
| 5 | AMGN Amgen | $336.23 | -0.07% | — | — | — | — | — | 49 |
| 6 | VRTX Vertex Pharma | $450.41 | -0.58% | — | — | — | — | — | 49 |
| 7 | LLY Eli Lilly | $1006.70 | -1.06% | — | — | — | — | — | 47 |
| 8 | GILD Gilead Sciences | $132.06 | -0.64% | — | — | — | — | — | 41 |
| 9 | BNTX BioNTech | $91.99 | -0.26% | — | — | — | — | — | 31 |